Literature DB >> 3276776

Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.

A Hamann1, D Jablonski-Westrich, A Duijvestijn, E C Butcher, H Baisch, R Harder, H G Thiele.   

Abstract

In a variety of lymphocyte interactions, lymphocyte function-associated antigen-1 (LFA-1) plays an important role as an accessory mechanism mediating cell adhesion. We tested the possibility that LFA-1 could also be involved in the specific binding of lymphocytes to high endothelial venules (HEV) during homing. Antibodies against LFA-1 but not against various other cell surface molecules (except the putative gp90 homing receptor defined by the MEL-14 antibody) were found to inhibit in vitro adherence of lymphocytes to HEV in frozen sections of lymph nodes. Binding of T cell lines to HEV was also inhibited by anti-LFA-1 antibody. Using sublines selected for differential expression of the MEL-14 antigen, MEL-14 high cells (which bind well to HEV) were less susceptible to inhibition by anti-LFA-1 than poor binders with low levels of the homing receptor, supporting the model of LFA-1 being an accessory mechanism strengthening weak interactions between cells. Parallel results were found in vivo where anti-LFA-1 antibodies reduced the migration of normal lymphocytes into lymph nodes and Peyer's patches by 40 to 60%. Localization in the lung, especially of activated lymphocytes, was also impaired, although to a lesser extent. These findings suggest that LFA-1 plays an accessory role in cellular interactions relevant for lymphocyte migration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276776

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

Review 1.  Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation.

Authors:  D A Steeber; T F Tedder
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice.

Authors:  Khairul Matin; M Abdus Salam; Joynab Akhter; Nobuhiro Hanada; Hidenobu Senpuku
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

3.  Blockade of leucocyte function-associated antigen-1 (LFA-1) decreases lymphocyte trapping in the normal pulmonary vasculature: studies in the isolated buffer-perfused rat lung.

Authors:  A Klemm; T Tschernig; L Ermert; A Althoff; M Merkle; A Gebert; M Ermert; W Seeger; R Pabst
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

4.  Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation.

Authors:  S A Bogen; H S Baldwin; S C Watkins; S M Albelda; A K Abbas
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

Review 5.  Lymphocyte homing into the gut.

Authors:  S Jalkanen
Journal:  Springer Semin Immunopathol       Date:  1990

Review 6.  Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium.

Authors:  S Jalkanen
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.

Authors:  Arno Hänninen; Rita Nurmela; Mikael Maksimow; Jarkko Heino; Sirpa Jalkanen; Christian Kurts
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

8.  Intravascular (angiotropic) large-cell lymphoma ('malignant angioendotheliomatosis') with small vessel pulmonary vascular obstruction and hypercalcemia.

Authors:  J L Curtis; M L Warnock; D J Conrad; L K Helfend; H A Boushey
Journal:  West J Med       Date:  1991-07

Review 9.  Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic.

Authors:  E C Butcher
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

10.  CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.

Authors:  Masahide Takedachi; Dongfeng Qu; Yukihiko Ebisuno; Hiroyuki Oohara; Michelle L Joachims; Stephanie T McGee; Emiko Maeda; Rodger P McEver; Toshiyuki Tanaka; Masayuki Miyasaka; Shinya Murakami; Thomas Krahn; Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.